> 지원 및 다운로드 > Quarterly Journal "TCIMAIL" > Back Numbers > c-Jun N-terminal kinase (JNK) Inhibitor: SU 3327

c-Jun N-terminal kinase (JNK) Inhibitor: SU 3327

No.178(July 2018)
A2940
SU 3327  (1)
SU 3327 (1) is a JNK (c-Jun N-terminal kinase) inhibitor developed based on structure-activity relationship studies.1) 1 inhibits activating transcription factor-2 (AFT-2) phosphorylation by JNK1 with IC50 = 0.7 μM in a substrate competitive manner. 1 also inhibits protein-protein interaction between JNK and JIP-1* with IC50 = 239 nM.
As one of the important roles JNK plays in the induction of autophagy via stimulations as shown in Table 1. It has been demonstrated that acute ethanol treatment decreased autophagy in mouse models and the decrease in autophagy was prevented by 1.2)
* JIP-1: JNK-interacting proteins (JIP) were identified as JNK scaffold proteins.3,4) JIP1 is a member of the JIP family and contains a JNK binding domain (JBD), a SRC homology (SH3) domain, and phosphotyrosine-binding (PTB) domain. JBD possesses the consensus sequence, R/KXXXXLXL.5) The probe, pep-JIP1, used in the reference (1), contains the sequence.

Table 1. Autophagy by various stimuli implicating JNK


These products are for research purpose only.

References

The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.